Efficacy of antimalarial drug treatments for uncomplicated falciparum and vivax malaria in selected Southeast Asian countries: A meta-analysis
Clicks: 1
ID: 284766
2023
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #3,734 of 3,757 articles by views in Malay Journal
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 3,757 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Antimalarial treatment varies extensively as its success is attributed to numerous factors such as patient’s health, comorbidities, infecting species, geographical region, and more. While the global malaria rate has been steadily decreasing, developing Southeast Asian countries are still at risk, especially with the decreasing efficacy of current antimalarial drugs due to drug resistance. This meta-analysis initially selected eight Southeast Asian countries, which were then finalized into five countries that had optimal data (Cambodia, Indonesia, Myanmar, Thailand, and Vietnam). Sixteen studies from these countries were selected to assess the efficacy of antimalarial treatments against Plasmodium falciparum and Plasmodium vivax. From the combination treatments, triple-based combination drug therapies have a higher relative mean efficacy compared to double-drug combinations. Against P. vivax, a t-test showed that Dihydroartemisinin-Piperaquine (DHA-PPQ) is superior compared to Chloroquine (CQ) alone (p < .001). Meanwhile, the mean efficacy of the drug therapies against P. falciparum was found to have a significant difference among the ten treatment groups (p < .001). The modified Tukey’s test formed four homogenous groups, and the group that had the highest mean efficacy against P. falciparum consisted of the following: Dihydroartemisinin-Piperaquine plus Artesunate (DHA-PPQ + AS), Dihydroartemisinin-Piperaquine plus Mefloquine (DHA-PPQ + MQ), Pyronaridine-Artesunate (PYN-AS), Artemether-Lumefantrine plus Amodiaquine (AL + AQ), and Pyrimethamine-Artesunate (PYR-AS). The mean age and treatment efficacy do not have any correlation (p = 0.1345). A t-test was performed to compare the efficacy of antimalarial drugs in the Thailand-Cambodia area in contrast to both Thailand and Cambodia. The results show that drug efficacy in the Thailand-Cambodia border is significantly lower (p < .001), which is attributed to the emergence of multidrug-resistant Plasmodium species in the area.
| Reference Key |
persistent_1760653620_68f171348a0e1
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Tansiongkun, Johan Christian T. |
| Journal | Malay Journal |
| Year | 2023 |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.